Extension Study of MT-1303 in Subjects With Crohn's Disease

NCT02389790 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Tanabe Pharma Corporation